12 February 2026 : Review article
Mechanism, Dose, and Administration of Dexmedetomidine in Managing Visceral Pain Associated With Surgery: A Narrative Review
Ruonan Tian EF 1, Zongming Jiang AEFG 1,2*, Han Zhou F 1, Yunzhi Wang F 2DOI: 10.12659/MSM.950564
Med Sci Monit 2026; 32:e950564
Table 1 Preclinical evidence of DEX ameliorates visceral pain.
| Year/Refs | Experimental subject | Animal model | DEX administration timing | DEX administration routes | Upward indicators | Reduction indicators | Results | Mechanism |
|---|---|---|---|---|---|---|---|---|
| 2008/[]42 | Wistar rats | Spinal cord Slice | Pretreatment | Superfusion | NR | NR | Hyperpolarizes the membrane potentials of spinal dorsal horn neurons | G-protein-mediated activation of K+ channels through a2AR |
| 2009/[]36 | Sprague-Dawley rats | Colorectal distension | Pretreatment | IV | NR | NR | Inhibits the colorectal distension-induced visceral nociceptive response | Opioid receptors |
| 2012/[]72 | Wistar rats | Surgical stress and pain | intraoperatively | IV | NR | NR | Attenuates surgical stress and pain-related reduction of microcirculatory blood flow intensity in intestinal mucosa and muscle | NR |
| 2014/[]48 | BALB/c mice | Endotoxemia | Pretreatment | Intraperitoneally | NR | Proinflammatory cytokine | Suppresses systemic inflammation | Cholinergic anti-inflammatory pathway |
| 2014/[]111 | Sprague-Dawley rats | Surgical induced inflammation | Pretreatment | Perineural sciatic injection | NR | IL-6 and TNF-α in sciatic nerve | DEX (perineural) exerts anti-inflammatory effects. | Inhibits the translocation of activated NF-κB to the nucleus and its binding activity, thus reducing inflammatory cytokines |
| 2015/[]37 | Wistar rats | NR | Pretreatment | Intrathecal administration | MWT | Substance P; CGRP | Antinociceptive effects | activation of α2 AR at the spinal cord level |
| 2015/[]74 | Sprague-Dawley rats | Intestinal I/R injury | 30 min prior to the intestinal I/R | Intraperitoneally | Bcl-2 | Intestinal NO levels; TNFα; IL6 | Exerts anti-inflammatory and anti-apoptotic properties in the intestine | Downregulated telomerase and caspase3mRNA |
| 2016/[]73 | Wistar rats | Endotoxemic model | Continuous infusion | IV | NR | Spleen bacterial colonies | Alleviates endotoxemia-related intestinal microcirculatory dysfunction. | Attenuates intestinal epithelial cell death, tight junction damage |
| 2017/[]53 | C57BL/6 mice | Heatstroke | Immediately after heatstroke | Intraperi-Toneally | NR | TNF-a;IL-6;IL-1β | Protects against heatstroke-induced inflammatory response and multi-organ dysfunction | Maintaining intestinal integrity and inhibiting enterocytes apoptosis |
| 2018/[]31 | Sprague-Dawley rats | Chronic post-ischemia pain | 1 h before reperfusion | Intraperi-Toneally | NR | pGluN1 and pERK expression in the spinal cord | Increase MWT | Inhibit the mechanical allodynia and central sensitization |
| 2018/[]56 | Sprague-Dawley rats | Acute IVP by acetic acid | 15 min before model establishment | Subdurally | MWT; TWL | Inflammatory cytokines | Relieves acute IVP | Decreases the activation of ERK, TLR4 signaling, and TRPV1 channel |
| 2019/[]47 | Sprague-Dawley rats | Chronic IVP | Pretreatment | Subdural injection | MWT; TWL | IL-1β; TNF-α; IL-6 | Suppresses visceral hypersensitivity | miR-34a-mediated HDAC2 pathway |
| 2019/[]54 | Sprague-Dawley rats | Acute liver injury | Pretreatment | Intraperitoneally | The expression of α7nAChR and ACh | Inflammatory cytokines | Significantly prevents LPS-induced acute liver injury | The TLR4/MyD88/NF-κB signaling pathway |
| 2019/[]62 | C57BL/6J mice | Traumatic brain injury | Immediately after trauma induction | IV | NR | Inflammatory cytokines | Down-regulate inflammatory cytokines. | Regulates the expression of CD40 and CD86 surface markers on macrophages |
| 2019/[]76 | Sprague-Dawley rats | orthotopic autologous liver transplant induced acute gut injury | 30 min before liver transplant | Intraperitoneally | The expression levels of occludin and ZO-1 | ROS | DEX exerts protective effects against acute gut injury | Activating Nrf2/HO-1 signaling to reduce oxidative stress |
| 2020/[]35 | Wistar rats | HO-induced dorsal root ganglion neurons | Pretreatment for 24 h | NR | NR | Cell apoptosis; ROS; anaerobic glycolysis | Inhibit HO-induced apoptosis | Inhibit ROS production |
| 2020/[]38 | Sprague-Dawley rats | Acute IVP | Pretreatment | Intrathecal injection | MWT; TWL | Proinflammatory cytokines | Suppresses acetic acid-induced visceral pain | Decrease signal transduction of the Keap1/Nrf2/HO-1 axis |
| 2020/[]49 | Sprague-Dawley rats | Severe acute pancreatitis | 30 min before induction of the model | Intraperitoneally | Frequency and amplitude discharge from cervical vagus nerve | TNF-α; IL-6; serum amylase | Alleviates the systematic inflammatory response and pancreatic injury | Cholinergic anti-inflammatory pathway |
| 2020/[]63 | C57BL/6 mice | Liver I/R injury | Pretreatment | Intraperitoneally | IL-10 | TNF-α; IL-6 | Effectively alleviates liver I/R injury. | Promoting macrophage M2 activation in a PPARγ/STAT dependent manner |
| 2021/[]52 | CD-1 male mice | Sepsis-associated encephalopathy | 5 min after cecal ligation and puncture | Intraperitoneally | NR | IL-1β; TNF-α; IL-6 | Attenuates sepsis-associated inflammation and encephalopathy | Via central α2AR |
| 2021/[]55 | C57BL/6 mice | Peritonitis was induced by zymosan A injection | 6 h after the installation of peritonitis | Intraperitoneally | Transforming growth factor-β1 | TNF-α; IL-1β | Promotes resolution of inflammation | Increases the CD11b+F4/80+Ly6G+ population in vivo |
| 2022/[]39 | Sprague-Dawley rats | Irritable bowel syndrome-like functional chronic visceral pain | Pretreatment | Epidural anesthesia | MWT;TWL | Abdominal withdrawal reflex | Inhibit visceral pain sensitivity | Activation of TLR4 in spinal dorsal horn |
| 2022/[]51 | C57BL/6J mice | Intestinal I/R | Pretreatment | Intraperitoneally | NR | Intestinal injury; norepinephrine; IL-1β; TNF-α | Alleviates cognitive dysfunction | Through the locus coeruleus norepinephrine system |
| 2022/[]75 | Sprague-Dawley rats | Cardio-pulmonary bypass | Pre-administration | IV | Anti-inflammatory cytokines | Proinflammatory factors | DEX pretreatment attenuates intestinal damage, inhibits inflammatory response | TLR4/JAK2/STAT3-mediated inflammatory pathway |
| 2023/[]34 | C57BL/6J mice | Formalin induced pain model | 30 min prior to formalin test | Intracranial injection | NR | NR | Ameliorates inflammatory pain | Upregulate Akt/GABAAR subunit complexes |
| CGRP – calcitonin gene-related peptide; DEX – dexmedetomidine; NR – No report; Refs – References; IV – intravenous injection; IL-6 – interleukin-6; TNF-α – tumor necrosis factor-α; MWT – mechanical withdrawal threshold; TWL – thermal withdrawal latency; NO – nitric oxide; α2AR – alpha 2 adrenoreceptor; I/R –ischemia/reperfusion; IVP – inflammatory visceral pain; ERK – extracellular regulated kinase; TLR4 – Toll-like receptor 4; TRPV1 – transient receptor potential vanilloid 1; LPS – lipopolysaccharide; TLR4/MyD88/NF-κB – Toll-like receptor 4/myeloid differentiation primary response gene 88/nuclear factor-κB; Nrf2/HO-1 – nuclear factor erythroid 2/hemooxygenase-1; ROS – reactive oxygen species; Keap1/Nrf2/HO-1 – Kelch-like ECH-associated protein 1/nuclear factor erythroid 2 related factor 2/hemooxygenase-1; PPARγ/STAT – peroxisome proliferator-activated receptor γ/signal transducer and activator of transcription; TLR4/JAK2/STAT3 – Toll-like receptor 4/Janus kinase2/signal transducer and activator of transcription; Akt/GABAAR – Akt/gamma-aminobutyric subunit A receptor; HDAC2 – histone deacetylase 2. | ||||||||






